• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

CHINARES PHARMA(03320.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec24
Huaxin Pharmaceutical Subsidiaries Obtain Clinical Trial Approval and Market Approval for New Drugs
06:15
Dec15
Huahuaipuoyi Commerce Completes RMB 3 Billion Medium-Term Note Issuance
12:40
Dec10
Huahuaikang Medicine's Two Drugs Included in National Health Insurance Directory
01:37
Dec2
Huahuaipharma Subsidiary's Pioglitazone Hydrochloride Dispersible Tablets Pass Consistency Evaluation
05:34
Nov20
China Resources Medicine Co., Ltd. Established with a Registered Capital of 30 Million RMB
07:41
Nov10
Shuren Sanjiu Secures Exclusive Rights to Helkos in China
09:48

Schedules & Filings

Schedules
Filings
Oct31
Distribution Plan(CST)

Cash dividend 0.0789 HKD

Sep12
Distribution Plan(CST)

Cash dividend 0.0789 HKD

Sep11
Distribution Plan(CST)

Cash dividend 0.0789 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00312
0.081
+68.75%
+0.033
01271
1.270
+45.98%
+0.400
00191
0.720
+44.00%
+0.220
01725
1.000
+42.86%
+0.300
01045
3.740
+34.53%
+0.960
08460
3.000
+32.74%
+0.740
00498
0.155
+29.17%
+0.035
02478
1.620
+26.56%
+0.340
08429
0.070
+25.00%
+0.014
08311
0.098
+24.05%
+0.019
View More